- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07908602
Hip Muscle Strengthening and Calf Myofascial Release in Females With Chronic Plantar Fasciitis
Effects of Hip Muscle Strengthening With and Without Myofascial Release of Calf Muscle on Pain and Disability in Females With Chronic Plantar Fasciitis.
This study aims to compare the effects of hip muscle strengthening with and without myofascial release of the calf muscle on pain and disability in females with chronic plantar fasciitis.
Chronic plantar fasciitis is a common cause of heel pain and may lead to limitations in walking, daily activities, and functional performance. Factors such as calf muscle tightness, restricted ankle dorsiflexion, altered lower-limb biomechanics, and proximal hip muscle weakness may contribute to persistent symptoms. Although strengthening exercises and myofascial release have shown beneficial effects, limited evidence is available regarding the combined effect of hip strengthening and calf myofascial release in females with chronic plantar fasciitis.
The study will be conducted as a randomized clinical trial with a total sample of 34 females, aged 25-45 years, who meet the specified criteria for chronic plantar fasciitis. Participants will be randomly allocated into two groups. Group A will receive hip muscle strengthening exercises, while Group B will receive the same strengthening program combined with myofascial release of the calf muscles. Both groups will receive treatment three times per week for six weeks, for a total of 18 sessions.
The primary outcome measures will include the Numeric Pain Rating Scale (NPRS), Foot Function Index (FFI), and Morning First-Step Pain Visual Analogue Scale (VAS). Assessments will be performed at baseline and after completion of the six-week intervention.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- UMT
-
Contact:
- Fizza Masood Dr., MS-OMPT
- Numéro de téléphone: +923344318731
- E-mail: fizza.masood@umt.edu.pk
-
Contact:
- Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT
- Numéro de téléphone: +923434570838
- E-mail: rabia.jawa@umt.edu.pk
-
Sous-enquêteur:
- Sadia Riaz
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Participants fulfilling the diagnostic criteria for plantar fasciitis.
- Age between 25-45 years.
- NPRS score between >3-6.
- History of chronic plantar heel pain for at least 3 consecutive months.
- Positive Windlass Test.
- Morning first-step pain intensity >5 cm on a 10-cm Visual Analog Scale (VAS).
Exclusion Criteria:
- Recent history of foot, ankle, or lower limb surgery.
- Corticosteroid injection for plantar fasciitis within the previous three months.
- Diagnosed neurological disorders affecting lower limb function.
- Pregnancy.
- Heel pain due to any other systemic inflammatory condition such as rheumatoid arthritis, gout, hyperuricemia (uric acid disorders), or other causes of heel pain.
- Foot or ankle fracture within the previous six months.
- Participation in any structured physiotherapy program for plantar fasciitis during the previous month.
- Presence of tarsal tunnel syndrome, Achilles tendon rupture, or other significant foot pathologies.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm 1: Hip muscles Strengthening Exercises
Participants will receive hip abductor strengthening exercises three sessions per week for six weeks to improve pain and functional outcomes associated with chronic plantar fasciitis. |
hip abductor strengthening exercises three sessions per week for six weeks |
|
Comparateur actif: Arm 2: Hip muscles Strengthening Exercises Combined with Calf Myofascial Release
Participants will receive hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks to evaluate the additional effects of calf myofascial release on pain and functional outcomes associated with chronic plantar fasciitis. |
hip muscles strengthening exercises combined with myofascial release of the calf muscles three sessions per week for six weeks |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Délai: Baseline and after 6 weeks
|
The Numeric Pain Rating Scale (NPRS) will be used to assess the intensity of pain associated with chronic plantar fasciitis. It is an 11-point numerical scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity. |
Baseline and after 6 weeks
|
|
Foot Function Index (FFI)
Délai: Baseline and after 6 weeks
|
The Foot Function Index (FFI) will be used to assess foot-related pain, disability, and activity limitation in females with chronic plantar fasciitis. The questionnaire evaluates the impact of foot symptoms on functional activities. Higher scores indicate greater pain and functional limitations. |
Baseline and after 6 weeks
|
|
Morning First-Step Pain Visual Analog Scale (VAS)
Délai: Baseline and after 6 weeks
|
The Visual Analog Scale (VAS) will be used to assess pain experienced during the first steps taken in the morning after a period of rest. Participants will indicate their pain intensity on a 10-cm visual analog line, with one end representing no pain and the other representing the worst imaginable pain. Higher scores indicate greater morning first-step pain. |
Baseline and after 6 weeks
|
Collaborateurs et enquêteurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- RE-165-2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The results data collected , de-identified individual participant data will be shared.
Délai de partage IPD
6 months after the publication of the manuscript.
Critères d'accès au partage IPD
The data can be requested from the corresponding author.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .